scFv intrabody targeting wildtype TDP-43 presents protective effects in a cellular model of TDP-43 proteinopathy

Saved in:
Bibliographic Details
Main Authors: Yara Al Ojaimi, Rudolf Hergesheimer, Anna A. Chami, Hugo Alarcan, Johanna Augros, Audrey Dangoumau, Shanez Haouari, Jérôme Bourgeais, Antoine Lefevre, Samira Osman, Patrick Emond, Patrick Vourc’h, Christian R. Andres, Philippe Corcia, Olivier Herault, Pierre Martineau, Débora Lanznaster, Hélène Blasco
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321133/?tool=EBI
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849392407697686528
author Yara Al Ojaimi
Rudolf Hergesheimer
Anna A. Chami
Hugo Alarcan
Johanna Augros
Audrey Dangoumau
Shanez Haouari
Jérôme Bourgeais
Antoine Lefevre
Samira Osman
Patrick Emond
Patrick Vourc’h
Christian R. Andres
Philippe Corcia
Olivier Herault
Pierre Martineau
Débora Lanznaster
Hélène Blasco
author_facet Yara Al Ojaimi
Rudolf Hergesheimer
Anna A. Chami
Hugo Alarcan
Johanna Augros
Audrey Dangoumau
Shanez Haouari
Jérôme Bourgeais
Antoine Lefevre
Samira Osman
Patrick Emond
Patrick Vourc’h
Christian R. Andres
Philippe Corcia
Olivier Herault
Pierre Martineau
Débora Lanznaster
Hélène Blasco
author_sort Yara Al Ojaimi
collection DOAJ
format Article
id doaj-art-643f57cca73b44c8bbcbc49db4f526e1
institution Kabale University
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-643f57cca73b44c8bbcbc49db4f526e12025-08-20T03:40:47ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01208scFv intrabody targeting wildtype TDP-43 presents protective effects in a cellular model of TDP-43 proteinopathyYara Al OjaimiRudolf HergesheimerAnna A. ChamiHugo AlarcanJohanna AugrosAudrey DangoumauShanez HaouariJérôme BourgeaisAntoine LefevreSamira OsmanPatrick EmondPatrick Vourc’hChristian R. AndresPhilippe CorciaOlivier HeraultPierre MartineauDébora LanznasterHélène Blascohttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321133/?tool=EBI
spellingShingle Yara Al Ojaimi
Rudolf Hergesheimer
Anna A. Chami
Hugo Alarcan
Johanna Augros
Audrey Dangoumau
Shanez Haouari
Jérôme Bourgeais
Antoine Lefevre
Samira Osman
Patrick Emond
Patrick Vourc’h
Christian R. Andres
Philippe Corcia
Olivier Herault
Pierre Martineau
Débora Lanznaster
Hélène Blasco
scFv intrabody targeting wildtype TDP-43 presents protective effects in a cellular model of TDP-43 proteinopathy
PLoS ONE
title scFv intrabody targeting wildtype TDP-43 presents protective effects in a cellular model of TDP-43 proteinopathy
title_full scFv intrabody targeting wildtype TDP-43 presents protective effects in a cellular model of TDP-43 proteinopathy
title_fullStr scFv intrabody targeting wildtype TDP-43 presents protective effects in a cellular model of TDP-43 proteinopathy
title_full_unstemmed scFv intrabody targeting wildtype TDP-43 presents protective effects in a cellular model of TDP-43 proteinopathy
title_short scFv intrabody targeting wildtype TDP-43 presents protective effects in a cellular model of TDP-43 proteinopathy
title_sort scfv intrabody targeting wildtype tdp 43 presents protective effects in a cellular model of tdp 43 proteinopathy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321133/?tool=EBI
work_keys_str_mv AT yaraalojaimi scfvintrabodytargetingwildtypetdp43presentsprotectiveeffectsinacellularmodeloftdp43proteinopathy
AT rudolfhergesheimer scfvintrabodytargetingwildtypetdp43presentsprotectiveeffectsinacellularmodeloftdp43proteinopathy
AT annaachami scfvintrabodytargetingwildtypetdp43presentsprotectiveeffectsinacellularmodeloftdp43proteinopathy
AT hugoalarcan scfvintrabodytargetingwildtypetdp43presentsprotectiveeffectsinacellularmodeloftdp43proteinopathy
AT johannaaugros scfvintrabodytargetingwildtypetdp43presentsprotectiveeffectsinacellularmodeloftdp43proteinopathy
AT audreydangoumau scfvintrabodytargetingwildtypetdp43presentsprotectiveeffectsinacellularmodeloftdp43proteinopathy
AT shanezhaouari scfvintrabodytargetingwildtypetdp43presentsprotectiveeffectsinacellularmodeloftdp43proteinopathy
AT jeromebourgeais scfvintrabodytargetingwildtypetdp43presentsprotectiveeffectsinacellularmodeloftdp43proteinopathy
AT antoinelefevre scfvintrabodytargetingwildtypetdp43presentsprotectiveeffectsinacellularmodeloftdp43proteinopathy
AT samiraosman scfvintrabodytargetingwildtypetdp43presentsprotectiveeffectsinacellularmodeloftdp43proteinopathy
AT patrickemond scfvintrabodytargetingwildtypetdp43presentsprotectiveeffectsinacellularmodeloftdp43proteinopathy
AT patrickvourch scfvintrabodytargetingwildtypetdp43presentsprotectiveeffectsinacellularmodeloftdp43proteinopathy
AT christianrandres scfvintrabodytargetingwildtypetdp43presentsprotectiveeffectsinacellularmodeloftdp43proteinopathy
AT philippecorcia scfvintrabodytargetingwildtypetdp43presentsprotectiveeffectsinacellularmodeloftdp43proteinopathy
AT olivierherault scfvintrabodytargetingwildtypetdp43presentsprotectiveeffectsinacellularmodeloftdp43proteinopathy
AT pierremartineau scfvintrabodytargetingwildtypetdp43presentsprotectiveeffectsinacellularmodeloftdp43proteinopathy
AT deboralanznaster scfvintrabodytargetingwildtypetdp43presentsprotectiveeffectsinacellularmodeloftdp43proteinopathy
AT heleneblasco scfvintrabodytargetingwildtypetdp43presentsprotectiveeffectsinacellularmodeloftdp43proteinopathy